These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31895946)

  • 1. How I treat anemia in heart failure.
    Anand I; Gupta P
    Blood; 2020 Aug; 136(7):790-800. PubMed ID: 31895946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia in chronic heart failure: can we treat? What to treat?
    von Haehling S; Anker MS; Jankowska EA; Ponikowski P; Anker SD
    Heart Fail Rev; 2012 Mar; 17(2):203-10. PubMed ID: 21979835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of anemia in heart failure patients].
    Santilli G; Tarantini L; Baio P; Senni M
    G Ital Cardiol (Rome); 2011 May; 12(5):319-26. PubMed ID: 21593950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and iron deficiency in heart failure.
    Gunawardena S; Dunlap ME
    Curr Heart Fail Rep; 2012 Dec; 9(4):319-27. PubMed ID: 22940847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    Barbieri C; Bolzoni E; Mari F; Cattinelli I; Bellocchio F; Martin JD; Amato C; Stopper A; Gatti E; Macdougall IC; Stuard S; Canaud B
    PLoS One; 2016; 11(3):e0148938. PubMed ID: 26939055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations.
    van der Meer P; Grote Beverborg N; Pfeffer MA; Olson K; Anand IS; Westenbrink BD; McMurray JJV; Swedberg K; Young JB; Solomon SD; van Veldhuisen DJ
    Circ Heart Fail; 2018 Feb; 11(2):e004431. PubMed ID: 29367268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Mc Causland FR; Claggett B; Burdmann EA; Chertow GM; Cooper ME; Eckardt KU; Ivanovich P; Levey AS; Lewis EF; McGill JB; McMurray JJV; Parfrey P; Parving HH; Remuzzi G; Singh AK; Solomon SD; Toto RD; Pfeffer MA
    Am J Kidney Dis; 2019 Mar; 73(3):309-315. PubMed ID: 30578152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.
    van Veldhuisen DJ; Anker SD; Ponikowski P; Macdougall IC
    Nat Rev Cardiol; 2011 May; 8(9):485-93. PubMed ID: 21629210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
    McMurray JJ; Anand IS; Diaz R; Maggioni AP; O'Connor C; Pfeffer MA; Polu KR; Solomon SD; Sun Y; Swedberg K; Tendera M; van Veldhuisen DJ; Wasserman SM; Young JB;
    Eur J Heart Fail; 2009 Aug; 11(8):795-801. PubMed ID: 19633103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose efficiency of erythropoiesis-stimulating agents for the treatment of patients with chemotherapy-induced anemia: a systematic review.
    Forbes CA; Worthy G; Harker J; Kleijnen J; Kutikova L; Zelek L; Van Belle S
    Clin Ther; 2014 Apr; 36(4):594-610. PubMed ID: 24656152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies.
    Anand IS; Gupta P
    Circulation; 2018 Jul; 138(1):80-98. PubMed ID: 29967232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.
    Mafodda A; Giuffrida D; Prestifilippo A; Azzarello D; Giannicola R; Mare M; Maisano R
    Support Care Cancer; 2017 Sep; 25(9):2779-2786. PubMed ID: 28391437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator.
    Yoshida T; Hayashi M
    Keio J Med; 2017 Sep; 66(3):44-50. PubMed ID: 27990008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia and heart failure.
    Ghali JK
    Curr Opin Cardiol; 2009 Mar; 24(2):172-8. PubMed ID: 19532104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and prescribing patterns for erythropoiesis-stimulating agents in inpatient and outpatient hospital settings.
    Siegel J; Jorgenson J; Johnson PE; Brophy DF; Comstock T; Feng A; Audhya P
    Am J Health Syst Pharm; 2008 Sep; 65(18):1711-9. PubMed ID: 18768997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaemia and iron deficiency in heart failure: epidemiological gaps, diagnostic challenges and therapeutic barriers in sub-Saharan Africa.
    Makubi A; Lwakatare J; Ogah OS; Rydén L; Lund LH; Makani J
    Cardiovasc J Afr; 2017; 28(5):331-337. PubMed ID: 29144533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
    Ghali JK; Anand IS; Abraham WT; Fonarow GC; Greenberg B; Krum H; Massie BM; Wasserman SM; Trotman ML; Sun Y; Knusel B; Armstrong P;
    Circulation; 2008 Jan; 117(4):526-35. PubMed ID: 18195176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study.
    Fuller DS; Robinson BM; Locatelli F; Pisoni RL
    Nephron; 2018; 140(1):24-30. PubMed ID: 29945128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials.
    Kang J; Park J; Lee JM; Park JJ; Choi DJ
    Int J Cardiol; 2016 Sep; 218():12-22. PubMed ID: 27209352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
    Ponikowski P; Anker SD; Szachniewicz J; Okonko D; Ledwidge M; Zymlinski R; Ryan E; Wasserman SM; Baker N; Rosser D; Rosen SD; Poole-Wilson PA; Banasiak W; Coats AJ; McDonald K
    J Am Coll Cardiol; 2007 Feb; 49(7):753-62. PubMed ID: 17306703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.